Search results
Found 1226 matches for
Neuroinflammation collaboration targeting inflammasome steps-up-the-pace in race for Alzheimer’s disease medicines that alleviate the burden of devastating disease
©
Alex Mit - Shutterstock
Longer-term organ abnormalities confirmed in some post-hospitalised COVID patients
Coronavirus COVID-19 General Research
25 September 2023
A study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.
Young people’s mental health deteriorated at greater rate during the pandemic
Coronavirus COVID-19 General Research
25 September 2023
Young people’s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit, a comprehensive new study has shown.
Oxford ranked third most intensive science and innovation cluster in the world
General
21 September 2023
The index establishes clusters through analysis of patent-filing activity and scientific article publication, documenting the geographical areas around the world with the highest density of inventors and scientific authors. This data forms part of the latest GII, which is due to be published in full later this month (Sept 27).
Study shows detrimental impact of Long Covid on the education and lives of children and young people
Coronavirus COVID-19 General Research
20 September 2023
New research from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, and the universities of Stirling and Aberdeen funded by the National Institute for Health and Care Research (NIHR), has shone a spotlight on the profound effect Long Covid can have on children and young people’s school experience and wider lives.
Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)
Clinical Trials General Research
19 September 2023
The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.
When it comes to starting a family, timing is everything
General Research
18 September 2023
The review, conducted jointly with researchers from Oxford University, the Royal Berkshire Hospital in Reading, and the Princess Anne Hospital in Southampton, included seven randomised controlled trials involving 2,464 women or couples who had been trying to conceive.
Continuing inequalities contribute to wide variation in rates of stillbirths and neonatal deaths across UK
General Research
18 September 2023
The MBRRACE-UK Collaboration, jointly led by Nuffield Department of Population Health’s National Perinatal Epidemiology Unit (NPEU) and the University of Leicester’s The Infant Mortality and Morbidity Studies (TIMMS) research group, has published a ‘State of the Nation’ report on perinatal deaths in babies born in the UK in 2021.
First volunteers receive vaccine for Crimean-Congo haemorrhagic fever in Oxford clinical trial
Clinical Trials General Research
13 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. Launched on the 4th of August 2023, the clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.
E-cigarettes, Varenicline and Cytisine found to be the most effective stop-smoking aids
General Research
13 September 2023
A comprehensive new analysis has found that nicotine e-cigarettes, varenicline and cytisine are the most effective options currently available for helping smokers quit long-term (going at least six months without smoking).
Three new Oxford-BMS Translational Fellowships announced
General Innovation Research
11 September 2023
Poor metabolic health could increase risk of developing dementia later in life
General Research
8 September 2023
Researchers at Nuffield Department of Population Health have found that having poor metabolic health was related to an increased risk of developing dementia in a study of more than 176,000 individuals.
New study disentangles a long-standing link between inflammation and cancer progression
General Research
5 September 2023
A new study led by the Mead Group in the MRC Weatherall Institute of Molecular Medicine (Radcliffe Department of Medicine) has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant haematopoietic stem cells.
Blood clots during COVID-19 may be a cause of ongoing cognitive problems
Coronavirus COVID-19 General Research
4 September 2023
High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including ‘brain fog’, giving a major clue as to one cause of their symptoms: blood clots.
Herman Waldmann awarded Royal Society Medal
Awards and Appointments General Research
30 August 2023
Professor Herman Waldmann FMedSci (Sir William Dunn School of Pathology) is one of four Oxford University researchers recognised today by the Royal Society.
New model predicts ten year breast cancer risk
General Research
25 August 2023
A team of researchers at the University of Oxford, led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
New study offers hope in early detection of oesophageal cancer
General Research
15 August 2023
Researchers at Oxford University's Nuffield Department of Primary Care Health Sciences have developed a new tool to predict people’s risks of getting oesophageal cancer in the next ten years.
Machine learning predicts SETD2 mutation status with unprecedented accuracy using DNA methylation
General Research
11 August 2023
In a pan-cancer analysis spanning 24 different cancer types, Department of Oncology researchers shed light on the critical role of SETD2 in tumourigenesis.
New Oxford study shows brief sleep therapy delivered by nurses improves insomnia
General Research
11 August 2023
Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
Nanopore technology achieves breakthrough in protein variant detection
General Research
7 August 2023
A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures. The method, published in Nature Nanotechnology, employs innovative nanopore technology to identify structural variations at the single-molecule level, even deep within long protein chains.
Oxford University team wins national teaching award
Awards and Appointments General
3 August 2023
The work of Oxford University’s Oxford Simulation, Teaching and Research team (OxSTaR) has been recognised by a Collaborative Award for Teaching Excellence (CATE). The AdvanceHE award celebrates outstanding collaborative impact on teaching and learning and highlights the key role of teamwork in higher education.